Life-Saving
Radioisotopes.
IsoMed Solutions leverages advanced enriched uranium technology to produce the world's most critical medical isotopes with unparalleled purity and reliability.
The Isotope Catalog
Our state-of-the-art facility utilizes High-Assay Low-Enriched Uranium (HALEU) targets to ensure a sustainable and secure supply chain for global medicine.
Molybdenum-99
The parent isotope of Technetium-99m, utilized in over 80% of all nuclear medicine procedures worldwide for imaging of the heart, lungs, and liver.
Key Application
Single Photon Emission Computed Tomography (SPECT)
Lutetium-177
A beta-emitting isotope used in targeted radionuclide therapy for neuroendocrine tumors and prostate cancer treatment.
Key Application
Theranostics & Precision Oncology
Iodine-131
Critical for both diagnosing and treating thyroid-related conditions, including hyperthyroidism and specific thyroid cancers.
Key Application
Thyroid Ablation Therapy
Xenon-133
A noble gas isotope primarily used for pulmonary ventilation studies to assess lung function and blood flow.
Key Application
Pulmonary Function Imaging
Yttrium-90
High-energy beta emitter used for radiation therapy of liver cancer and in some cases, rheumatoid arthritis treatment.
Key Application
Radioembolization (SIRT)
Strontium-89
Specifically targeted for skeletal metastases, providing significant pain relief for patients with advanced bone cancer.
Key Application
Palliative Bone Pain Relief
Purity Standards & Compliance
99.9% Specific Activity
Meeting and exceeding pharmacopeia standards for chemical and radiochemical purity.
LEU-Based Production
Non-proliferation compliant production pipelines using Low-Enriched Uranium.
Supply Chain Logistics
Isotope Variations
Patient Doses Daily
Production Downtime